跳至主要内容
临床试验/NCT00116883
NCT00116883已完成3 期

A Randomized, Double-blind, Parallel Group, Placebo Controlled, 6-week Study of the Effect of GW685698X Aqueous Nasal Spray 100mcg QD on the Hypothalamic Pituitary Adrenocortical (HPA) Axis in Children 2 to 11 Years of Age With Perennial Allergic Rhinitis (PAR).

GlaxoSmithKline1 个研究点 分布在 1 个国家目标入组 90 人开始时间: 2005年2月最近更新:
适应症
干预措施

试验速览

阶段
3 期
状态
已完成
入组人数
90
试验地点
1
主要终点
HPA axis function at baseline and after 6 weeks of treatment as measured by 24 hour urine and serial serum cortisol assessments in domiciled subjects

研究概览

简要总结

The purpose of this study is to assess the effect of an aqueous nasal spray investigational compound GW685698X compared to placebo on the hypothalamic pituitary adrenocortical (HPA) axis system in children 2 to 11 years of age with perennial allergic rhinitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
2 Years 至 11 Years(Child)
性别
All
接受健康志愿者

入选标准

  • 未提供

排除标准

  • 未提供

研究组 & 干预措施

Arm 1

Experimental

干预措施: GW685698X aqueous nasal spray (Drug)

结局指标

主要结局

HPA axis function at baseline and after 6 weeks of treatment as measured by 24 hour urine and serial serum cortisol assessments in domiciled subjects

次要结局

  • Results of adverse event, laboratory, nasal examination, vital sign, ECG and pharmacokinetic assessments.

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

A Study Of GW685698X For The Treatment Of Perennial... | 临床试验